Loading institutional data...
Loading institutional data...
Institutional distribution: ownership decreased -0.96% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $2.98 today, the market must believe free cash flow compounds -2.9%/yr for a decade (off $2M normalized FCF).
2-stage DCF · 0.01B shares · net debt $2M
mean -355.1% · volatility σ 247% · implied rate exceeded in 0/2 yrs
Central path = implied -2.9%/yr growth; shaded band = ±1σ (247%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 17 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 651 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $29.49T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $371.6B | 42.5× | 29.7× | 5.5× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $328.8B | 38.5× | — | 7.2× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $259.8B | 39.0× | 18.5× | 2.9× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| BA | $199.4B | 79.4× | 40.2× | 2.2× | 34.5% | 4.8% | 2.5% | 41.0% | 3.3% | 10.0× | 2,435 |
| DE | $185.4B | 37.1× | — | 4.1× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| ABBNY | $177.4B | 47.9× | 31.6× | 5.5× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $167.6B | 23.6× | 16.1× | 6.8× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $158.8B | 39.2× | — | 5.8× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| HON | $131.2B | 28.1× | 16.1× | 3.5× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| LMT | $123.2B | 25.0× | 16.1× | 1.6× | 5.6% | 10.2% | 6.7% | 74.6% | 17.7% | 2.5× | 2,807 |
| PH | $118.7B | 34.1× | 26.8× | 6.0× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| ADP | $108.3B | 24.9× | — | 4.9× | 6.7% | 46.4% | 20.1% | 73.2% | 40.1% | — | 2,179 |
| GD | $96.2B | 23.0× | 16.9× | 1.8× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| TT | $94.4B | 32.6× | 23.3× | 4.4× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| VRT | $92.4B | 70.8× | 43.8× | 9.0× | 27.7% | 36.3% | 13.0% | 33.8% | 19.4% | 1.4× | 1,748 |
| PWR | $92.2B | 90.7× | 45.8× | 3.2× | 20.3% | 15.0% | 3.6% | 11.5% | 10.6% | 0.4× | 1,659 |
| JCI | $91.9B | 28.0× | — | 3.9× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| HWM | $90.7B | 60.9× | 39.9× | 11.0× | 11.1% | — | 18.3% | 28.2% | 17.9% | 1.3× | 1,399 |
| CSX | $89.1B | 31.1× | 14.4× | 6.3× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| MMM | $87.3B | 27.4× | 16.8× | 3.5× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| WM | $86.0B | 31.8× | 12.1× | 3.4× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| UPS | $85.0B | 15.3× | 9.5× | 1.0× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| EMR | $83.0B | 36.5× | — | 4.6× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| CTAS | $79.8B | 45.0× | 28.7× | 7.7× | 7.7% | 50.0% | 17.5% | 38.7% | 25.5% | 0.8× | 1,366 |
| ARTW | $15M | 14.9× | 16.3× | 0.7× | -6.2% | 27.3% | 4.5% | 7.8% | 6.6% | 2.3× | 17 |
Peers = companies sharing ARTW's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.0M 100.0% | $24.5M 100.0% | $30.3M 100.0% | — | $25.6M 100.0% | — | $25.0M 100.0% | $22.4M 100.0% | $22.9M 100.0% | $19.7M 100.0% |
| Cost of Revenue | $16.7M 72.7% | $17.2M 70.2% | $21.7M 71.7% | — | $18.7M 72.9% | — | $18.4M 73.6% | $20.0M 89.3% | $19.0M 82.8% | $16.2M 82.2% |
| Gross Profit | $6.3M 27.3% | $7.3M 29.8% | $8.6M 28.3% | — | $6.9M 27.1% | — | $6.6M 26.4% | $2.4M 10.7% | $3.9M 17.2% | $3.5M 17.8% |
| Research & Development | $228K 1.0% | $216K 0.9% | $204K 0.7% | — | $193K 0.8% | — | $152K 0.6% | $199K 0.9% | $149K 0.7% | $178K 0.9% |
| Selling, General & Admin | $4.2M 18.3% | $4.8M 19.5% | $4.3M 14.3% | — | $3.8M 15.0% | — | $3.6M 14.2% | $4.2M 18.8% | $3.3M 14.6% | $3.4M 17.4% |
| Total Operating Expenses | $6.0M 26.0% | $6.8M 28.0% | $7.1M 23.3% | — | $6.3M 24.7% | — | $6.1M 24.3% | $6.3M 28.2% | $5.4M 23.7% | $6.6M 33.5% |
| Operating Income | $289K 1.3% | $461K 1.9% | $1.5M 5.1% | — | $605K 2.4% | — | $523K 2.1% | -$3.9M -17.4% | -$1.5M -6.5% | -$3.1M -15.7% |
| Interest Expense | $367K 1.6% | $599K 2.4% | $590K 1.9% | — | $404K 1.6% | — | $313K 1.3% | $305K 1.4% | $358K 1.6% | $305K 1.5% |
| Other Income (Expense), net | $1.1M 5.0% | -$596K -2.4% | -$442K -1.5% | — | -$164K -0.6% | — | -$257K -1.0% | $950K 4.2% | -$272K -1.2% | -$751K -3.8% |
| Pretax Income | $1.4M 6.3% | -$135K -0.6% | $1.1M 3.6% | — | $441K 1.7% | — | $267K 1.1% | -$3.0M -13.2% | -$1.8M -7.7% | -$3.8M -19.5% |
| Income Tax Expense | $402K 1.8% | -$41K -0.2% | $326K 1.1% | — | $67K 0.3% | — | $54K 0.2% | -$856K -3.8% | -$349K -1.5% | -$510K -2.6% |
| Net Income | $1.0M 4.5% | $307K 1.3% | $267K 0.9% | $342K | $98K 0.4% | -$406K | $213K 0.9% | -$2.1M -9.4% | -$1.4M -6.2% | -$3.4M -17.2% |
| Per Share | ||||||||||
| EPS (Basic) | $0.20 | $0.06 | $0.05 | $0.07 | $0.02 | $-0.09 | $0.05 | $-0.48 | $-0.33 | $-0.81 |
| EPS (Diluted) | $0.20 | $0.06 | $0.05 | $0.07 | $0.02 | $-0.09 | $0.05 | $-0.48 | $-0.33 | $-0.81 |
| Weighted Avg Shares (Basic) | 5.1M | 5.1M | 5.0M | 5.0M | 4.7M | 4.6M | 4.5M | 4.4M | 4.3M | 4.2M |
| Weighted Avg Shares (Diluted) | 5.1M | 5.1M | 5.0M | 5.0M | 4.7M | 4.6M | 4.5M | 4.4M | 4.3M | 4.2M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $1542 buybacks = $1542 returned on -$2M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 7%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $4849 is below the $177519 due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2021-11-30 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~14.7% on $2M of debt.
Cash of $4849 is below short-term debt of $165326 — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
No standout strengths flagged.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 6.0× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2020 | FY2021 | FY2022 | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 89.3 | 73.6 | — | 72.9 | — | 71.7 | 70.2 | 72.7 |
| Gross Profit | 10.7 | 26.4 | — | 27.1 | — | 28.3 | 29.8 | 27.3 |
| R&D | 0.9 | 0.6 | — | 0.8 | — | 0.7 | 0.9 | 1.0 |
| SG&A | 18.8 | 14.2 | — | 15.0 | — | 14.3 | 19.5 | 18.3 |
| Operating Income | -17.4 | 2.1 | — | 2.4 | — | 5.1 | 1.9 | 1.3 |
| Income Tax | -3.8 | 0.2 | — | 0.3 | — | 1.1 | -0.2 | 1.8 |
| Net Income | -9.4 | 0.9 | — | 0.4 | — | 0.9 | 1.3 | 4.5 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ARTW: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.